Skip to main content
SpringerLink
Log in

What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers’ and Patients’ Perceptions of, and Experiences with, Generic Medicines

  • Systematic Review
  • Published:
The Patient - Patient-Centered Outcomes Research Aims and scope Submit manuscript

Abstract

Background and Objective

Considerable emphasis is placed on the use of generic medicines because of the potential economic benefits associated with their use. The objective of this systematic review is to compile and collate published research regarding patient/consumer perceptions and attitudes in relation to generic medicines, aiming to describe such views and detail patient experiences with generic medicines.

Methods

Literature published between 2005 and July 2015, indexed in PubMed, Scopus and EMBASE, on the topic of consumer or patient opinions of generic medicines were collated, using systematic searches, and appraised.

Results

A total of 59 papers were reviewed. Familiarity and trust in brand names appears to be a substantial barrier to the increased use of generics, with patients also appearing to hold the view that if a product is cheaper, then it must not be as good. Some publications report positive views of generics, with positively inclined consumers stating that they did not perceive any difference between a generic and the proprietary medicine. Acceptance of generics appears to be higher in consumers with higher levels of education while patients from lower socioeconomic demographic groups tend to have greater mistrust of generics.

Conclusions

The provision of information to consumers that dispels myths about generics may improve confidence in generic medicines. As patients demonstrate a high degree of trust in physicians, their opinions can impact on patient/consumer opinions. Therefore, enhancing the perceptions of generics held by physicians is likely to have a positive impact on patient/consumer opinions of, and trust in, generic medications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. World Health Organisation. Generic drugs. Available from http://www.who.int/trade/glossary/story034/en/index.html. Accessed 26 Apr 2016.

  2. European Medicines Agency. EMA Q&A on generic medicine. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Medicine_QA/2009/11/WC500012382.pdf. Accessed 26 Apr 2016.

  3. Dunne S, Shannon B, Dunne C, Cullen W. A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study. BMC Pharmacol Toxicol. 2013;14(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  4. World Health Organisation. WHO drug information volume 28, No. 1, 2014. Available from: http://www.who.int/medicines/publications/druginformation/issues/DrugInformation2014_Vol28-1/en/. Accessed 21 June 2015.

  5. OECD. What Future for Health Spending? In: OECD Economics Department policy notes, No. 19. . 2013. Available from: http://www.oecd.org/economy/health-spending.pdf. Accessed 21 June 2015.

  6. Dunne SS, Dunne CP. What do people really think of generic medicines? A systematic review and critical appraisal of literature on stakeholder perceptions of generic drugs. BMC Med. 2015;13:173. doi:10.1186/s12916-015-0415-3.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Al Ameri MN, Mohamed W, Makramalla E, Shalhoub B, Tucker A, Johnston A. Renal patients’ views on generic prescribing and substitution: example from the United Arab Emirates. Eastern Med Health J. 2013;19(4):373–81.

    CAS  Google Scholar 

  8. Al Ameri MN, Whittaker C, Tucker A, Yaqoob M, Johnston A. A survey to determine the views of renal transplant patients on generic substitution in the UK. Transplant Int. 2011;24(8):770–9. doi:10.1111/j.1432-2277.2011.01268.x.

    Article  Google Scholar 

  9. Al-Gedadi NA, Hassali MA, Shafie AA. A pilot survey on perceptions and knowledge of generic medicines among consumers in Penang, Malaysia. Pharm Pract (Granada). 2008;6(2):93–7.

    Article  Google Scholar 

  10. Babar ZU, Stewart J, Reddy S, Alzaher W, Vareed P, Yacoub N, et al. An evaluation of consumers’ knowledge, perceptions and attitudes regarding generic medicines in Auckland. Pharmacy World Sci. 2010;32(4):440–8. doi:10.1007/s11096-010-9402-0.

    Article  Google Scholar 

  11. Berg MJ, Gross RA, Haskins LS, Zingaro WM, Tomaszewski KJ. Generic substitution in the treatment of epilepsy: patient and physician perceptions. Epilepsy Behav. 2008;13(4):693–9. doi:10.1016/j.yebeh.2008.06.001.

    Article  PubMed  Google Scholar 

  12. Bertoldi AD, Barros AJ, Hallal PC. Generic drugs in Brazil: known by many, used by few. Cad Saude Publica. 2005;21(6):1808–15.

    Article  PubMed  Google Scholar 

  13. Bulsara C, McKenzie A, Sanfilippo F, Holman CD, Emery JE. ‘Not the full Monty’: a qualitative study of seniors’ perceptions of generic medicines in Western Australia. Aust J Primary Health. 2010;16(3):240–5. doi:10.1071/py10006.

    Article  Google Scholar 

  14. Chong CP, March G, Clark A, Gilbert A, Hassali MA, Bahari MB. A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance. Health Policy. 2011;99(2):139–48. doi:10.1016/j.healthpol.2010.08.002.

    Article  PubMed  Google Scholar 

  15. Choudhry NK, Cox E, Fischer MA, Mehta J, Shrank WH. Setting prices for generic medications: a survey of patients perceptions. Am J Pharm Benefits. 2010;2(1):33–8.

    Google Scholar 

  16. Costa-Font J, Rudisill C, Tan S. Brand loyalty, patients and limited generic medicines uptake. Health Policy. 2014;116(2–3):224–33. doi:10.1016/j.healthpol.2014.01.015.

    Article  PubMed  Google Scholar 

  17. Drozdowska A, Hermanowski T. Exploring the opinions and experiences of patients with generic substitution: a representative study of Polish society. Int J Clin Pharm. 2015;37(1):68–75. doi:10.1007/s11096-014-0041-8.

    Article  PubMed  Google Scholar 

  18. Dunne S, Shannon B, Dunne C, Cullen W. Patient perceptions of generic medicines: a mixed-methods study. Patient. 2014;7(2):177–85. doi:10.1007/s40271-013-0042-z.

    Article  PubMed  Google Scholar 

  19. El-Dahiyat F, Kayyali R. Evaluating patients’ perceptions regarding generic medicines in Jordan. J Pharm Policy Pract. 2013;6:3. doi:10.1186/2052-3211-6-3.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Figueiras MJ, Alves NC, Marcelino D, Cortes MA, Weinman J, Horne R. Assessing lay beliefs about generic medicines: development of the generic medicines scale. Psychol Health Med. 2009;14(3):311–21. doi:10.1080/13548500802613043.

    Article  PubMed  Google Scholar 

  21. Figueiras MJ, Marcelino D, Cortes MA. People’s views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590–4. doi:10.1007/s11096-008-9247-y.

    Article  PubMed  Google Scholar 

  22. Fraeyman J, Peeters L, Van Hal G, Beutels P, De Meyer GR, De Loof H. Consumer choice between common generic and brand medicines in a country with a small generic market. J Manag Care Spec Pharm. 2015;21(4):288–96.

    Article  PubMed  Google Scholar 

  23. Frisk P, Rydberg T, Carlsten A, Ekedahl A. Patients’ experiences with generic substitution: a Swedish pharmacy survey. J Pharm Health Serv Res. 2011;2(1):9–15. doi:10.1111/j.1759-8893.2011.00036.x.

    Article  Google Scholar 

  24. Hakonsen H, Eilertsen M, Borge H, Toverud EL. Generic substitution: additional challenge for adherence in hypertensive patients? Curr Med Res Opin. 2009;25(10):2515–21. doi:10.1185/03007990903192223.

    Article  CAS  PubMed  Google Scholar 

  25. Hakonsen H, Toverud EL. Special challenges for drug adherence following generic substitution in Pakistani immigrants living in Norway. Eur J Clin Pharmacol. 2011;67(2):193–201. doi:10.1007/s00228-010-0960-9.

    Article  PubMed  Google Scholar 

  26. Halme M, Linden K, Kaaria K. Patients’ preferences for generic and branded over-the-counter medicines: an adaptive conjoint analysis approach. Patient. 2009;2(4):243–55. doi:10.2165/11314130-000000000-00000.

    Article  PubMed  Google Scholar 

  27. Hassali MA, Kong DCM, Stewart K. Generic medicines: perceptions of consumers in Melbourne, Australia. Int J Pharm Pract. 2005;13(4):257–64. doi:10.1211/ijpp.13.4.0004.

    Article  Google Scholar 

  28. Heikkila R, Mantyselka P, Ahonen R. Do people regard cheaper medicines effective? Population survey on public opinion of generic substitution in Finland. Pharmacoepidemiol Drug Saf. 2011;20(2):185–91. doi:10.1002/pds.2084.

    Article  PubMed  Google Scholar 

  29. Heikkilä R, Mäntyselkä P, Ahonen R. Why people refuse generic substitution: a population survey of public opinion on generic substitution in Finland. Drugs Ther Perspect. 2012;28(8):24–6.

    Google Scholar 

  30. Heikkilä R, Mäntyselkä P, Hartikainen-Herranen K, Ahonen R. Customers’ and physicians’ opinions of and experiences with generic substitution during the first year in Finland. Health Policy. 2007;82(3):366–74. doi:10.1016/j.healthpol.2006.10.006.

    Article  PubMed  Google Scholar 

  31. Hensler K, Uhlmann C, Porschen T, Benecke R, Rösche J. Generic substitution of antiepileptic drugs: a survey of patients’ perspectives in Germany and other German-speaking countries. Epilepsy Behav. 2013;27(1):135–9. doi:10.1016/j.yebeh.2012.12.029.

    Article  PubMed  Google Scholar 

  32. Himmel W, Simmenroth-Nayda A, Niebling W, Ledig T, Jansen RD, Kochen MM, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther. 2005;43(10):472–9.

    Article  CAS  PubMed  Google Scholar 

  33. Hulbert AL, Pilch NA, Taber DJ, Chavin KD, Baliga PK. Generic immunosuppression: deciphering the message our patients are receiving. Ann Pharmacother. 2012;46(5):671–7. doi:10.1345/aph.1R028.

    Article  PubMed  Google Scholar 

  34. Ibrahim R, McKinnon RA, Ngo SNT. Knowledge and perceptions of community patients about generic medicines. J Pharm Pract Res. 2012;42(4):283–6. doi:10.1002/j.2055-2335.2012.tb00189.x.

    Article  Google Scholar 

  35. Iosifescu A, Halm EA, McGinn T, Siu AL, Federman AD. Beliefs about generic drugs among elderly adults in hospital-based primary care practices. Patient Educ Couns. 2008;73(2):377–83. doi:10.1016/j.pec.2008.07.012.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Jacomet C, Allavena C, Peyrol F, Pereira B, Joubert LM, Bagheri H, et al. Perception of antiretroviral generic medicines: one-day survey of HIV-infected patients and their physicians in France. PloS One. 2015;10(2):e0117214. doi:10.1371/journal.pone.0117214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Keenum AJ, Devoe JE, Chisolm DJ, Wallace LS. Generic medications for you, but brand-name medications for me. Res Social Admin Pharm. 2012;8(6):574–8. doi:10.1016/j.sapharm.2011.12.004.

    Article  Google Scholar 

  38. Kjoenniksen I, Lindbaek M, Granas AG. Patients’ attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci. 2006;28(5):284–9. doi:10.1007/s11096-006-9043-5.

    Article  PubMed  Google Scholar 

  39. Kobayashi E, Karigome H, Sakurada T, Satoh N, Ueda S. Patients’ attitudes towards generic drug substitution in Japan. Health Policy. 2011;99(1):60–5. doi:10.1016/j.healthpol.2010.07.006.

    Article  PubMed  Google Scholar 

  40. Kohli E, Buller A. Factors influencing consumer purchasing patterns of generic versus brand name over-the-counter drugs. Southern Med J. 2013;106(2):155–60. doi:10.1097/SMJ.0b013e3182804c58.

    Article  PubMed  Google Scholar 

  41. Lebanova H, Manolov D, Getov I. Patients’ attitude about generics: Bulgarian perspective. Marmara Pharm J. 2012;16:36–40. doi:10.12991/201216418.

    Article  Google Scholar 

  42. McAuley JW, Chen AY, Elliott JO, Shneker BF. An assessment of patient and pharmacist knowledge of and attitudes toward reporting adverse drug events due to formulation switching in patients with epilepsy. Epilepsy Behav. 2009;14(1):113–7. doi:10.1016/j.yebeh.2008.08.009.

    Article  PubMed  Google Scholar 

  43. Ngo SN, Stupans I, McKinnon RA. Generic substitution in the treatment of epilepsy: patient attitudes and perceptions. Epilepsy Behav. 2013;26(1):64–6. doi:10.1016/j.yebeh.2012.10.032.

    Article  PubMed  Google Scholar 

  44. Omojasola A, Gor B, Jones L. Perceptions of generic drug discount programs among low-income women: a qualitative study. Women Health Issues. 2013;23(1):e55–60. doi:10.1016/j.whi.2012.10.002.

    Article  Google Scholar 

  45. Omojasola A, Hernandez M, Sansgiry S, Jones L. Perception of generic prescription drugs and utilization of generic drug discount programs. Ethn Dis. 2012;22(4):479–85.

    PubMed  PubMed Central  Google Scholar 

  46. Palagyi M, Lassanova M. Patients attitudes towards experience with use of generics in Slovakia, performance of generic substitution. Bratisl Lek Listy. 2008;109(7):324–8.

    CAS  PubMed  Google Scholar 

  47. Papsdorf TB, Ablah E, Ram S, Sadler T, Liow K. Patient perception of generic antiepileptic drugs in the midwestern United States. Epilepsy Behav. 2009;14(1):150–3. doi:10.1016/j.yebeh.2008.09.009.

    Article  PubMed  Google Scholar 

  48. Patel A, Gauld R, Norris P, Rades T. “This body does not want free medicines”: South African consumer perceptions of drug quality. Health Policy Plan. 2010;25(1):61–9. doi:10.1093/heapol/czp039.

    Article  PubMed  Google Scholar 

  49. Patel A, Gauld R, Norris P, Rades T. Quality of generic medicines in South Africa: perceptions versus reality: a qualitative study. BMC Health Serv Res. 2012;12:297. doi:10.1186/1472-6963-12-297.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Pereira JA, Holbrook AM, Dolovich L, Goldsmith C, Thabane L, Douketis JD, et al. Are brand-name and generic warfarin interchangeable? A survey of Ontario patients and physicians. Can J Clin Pharmacol. 2005;12(3):e229–39.

    PubMed  Google Scholar 

  51. Piette JD, Heisler M, Harand A, Juip M. Beliefs about prescription medications among patients with diabetes: variation across racial groups and influences on cost-related medication underuse. J Health Care Poor Underserved. 2010;21(1):349–61. doi:10.1353/hpu.0.0247.

    Article  PubMed  Google Scholar 

  52. Quintal C, Mendes P. Underuse of generic medicines in Portugal: an empirical study on the perceptions and attitudes of patients and pharmacists. Health Policy. 2012;104(1):61–8. doi:10.1016/j.healthpol.2011.10.001.

    Article  PubMed  Google Scholar 

  53. Rathe J, Andersen M, Jarbol DE, dePont Christensen R, Hallas J, Sondergaard J. Generic switching and non-persistence among medicine users: a combined population-based questionnaire and register study. PloS One. 2015;10(3):e0119688. doi:10.1371/journal.pone.0119688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Rathe J, Larsen P, Andersen M, Paulsen M, Jarbol D, Thomsen J, et al. Associations between generic substitution and patients’ attitudes, beliefs and experiences. Eur J Clin Pharmacol. 2013;69(10):1827–36. doi:10.1007/s00228-013-1539-z.

    Article  PubMed  Google Scholar 

  55. Rathe J, Sondergaard J, Jarbol DE, Hallas J, Andersen M. Patients’ concern about their medicine after a generic switch: a combined cross-sectional questionnaire and register study. Pharmacoepidemiol Drug Saf. 2014;23(9):965–73. doi:10.1002/pds.3671.

    Article  PubMed  Google Scholar 

  56. Roman B. Patients’ attitudes towards generic substitution of oral atypical antipsychotics: a questionnaire-based survey in a hypothetical pharmacy setting. CNS Drugs. 2009;23(8):693–701. doi:10.2165/00023210-200923080-00006.

    Article  PubMed  Google Scholar 

  57. Sansgiry SS, Bhosle M, Pope N. Consumer perceptions regarding generic drug substitution: an exploratory study. J Pharm Mark Manag. 2005;17(1):77–91. doi:10.3109/J058v17n01_06.

    Article  Google Scholar 

  58. Sewell K, Andreae S, Luke E, Safford MM. Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011. Prevent Chronic Dis. 2012;9:E142. doi:10.5888/pcd9.120010.

    Google Scholar 

  59. Sharrad AK, Hassali MA. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study. Res Social Admin Pharm. 2011;7(1):108–12. doi:10.1016/j.sapharm.2009.12.003.

    Article  Google Scholar 

  60. Shrank WH, Cadarette SM, Cox E, Fischer MA, Mehta J, Brookhart AM, et al. Is there a relationship between patient beliefs or communication about generic drugs and medication utilization? Med Care. 2009;47(3):319–25. doi:10.1097/MLR.0b013e31818af850.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Shrank WH, Cox ER, Fischer MA, Mehta J, Choudhry NK. Patients’ perceptions of generic medications. Health Affairs. 2009;28(2):546–56. doi:10.1377/hlthaff.28.2.546.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Sicras-Mainar A, Navarro-Artieda R. Physicians’ and patients’ opinions on the use of generic drugs. J Pharmacol Pharmacother. 2012;3(3):268–70. doi:10.4103/0976-500x.99438.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Toklu HZ, Dulger GA, Hidiroglu S, Akici A, Yetim A, Gannemoglu HM, et al. Knowledge and attitudes of the pharmacists, prescribers and patients towards generic drug use in Istanbul, Turkey. Pharm Pract (Granada). 2012;10(4):199–206.

    Article  Google Scholar 

  64. Toverud EL, Hartmann K, Hakonsen H. A systematic review of physicians’ and pharmacists’ perspectives on generic drug use: what are the global challenges? Appl Health Econ Health Policy. 2015;13(1):35–45.

    Article  PubMed Central  Google Scholar 

  65. Toverud EL, Roise AK, Hogstad G, Wabo I. Norwegian patients on generic antihypertensive drugs: a qualitative study of their own experiences. Eur J Clin Pharmacol. 2011;67(1):33–8. doi:10.1007/s00228-010-0935-x.

    Article  PubMed  Google Scholar 

  66. Wong ZY, Hassali MA, Alrasheedy AA, Saleem F, Yahaya AH, Aljadhey H. Patients’ beliefs about generic medicines in Malaysia. Pharm Pract. 2014;12(4):474.

    Google Scholar 

  67. International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals. 2015. Available from: http://www.icmje.org/icmje-recommendations.pdf. Accessed 15 Jan 2016.

  68. Kesselheim AS, Misono AS, Lee JL, Stedman MR, Brookhart MA, Choudhry NK, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514–26. doi:10.1001/jama.2008.758.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. US FDA. Review of therapeutic equivalence generic Bupropion XL 300 mg and Wellbutrin XL 300 mg. FDA, FDA website. 2013. Available from: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm153270.htm. Accessed 22 Nov 2014.

  70. US FDA. Methylphenidate hydrochloride extended release tablets (generic Concerta) made by Mallinckrodt and Kudco. FDA, FDA website. 2015. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm422568.htm. Accessed 22 Nov 2014.

  71. Kesselheim AS, Bykov K, Avorn J, Tong A, Doherty M, Choudhry NK. Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med. 2014;161(2):96–103.

    Article  PubMed  Google Scholar 

  72. US FDA. Size, shape, and other physical attributes of generic tablets and capsules: guidance for Industry. US FDA. 2015. Available from: http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm377938.pdf. Accessed 15 Jan 2016.

Download references

Author information

Authors and Affiliations

  1. Centre for Interventions in Infection, Inflammation and Immunity (4i) and Graduate Entry Medical School, University of Limerick, Castletroy, Limerick, V94 T9PX, Ireland

    Suzanne S. Dunne

Authors
  1. Suzanne S. Dunne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suzanne S. Dunne.

Ethics declarations

The author declares that there is no conflict of interest. No funding was received to perform this study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dunne, S.S. What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers’ and Patients’ Perceptions of, and Experiences with, Generic Medicines. Patient 9, 499–510 (2016). https://doi.org/10.1007/s40271-016-0176-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40271-016-0176-x

Keywords

Search

Navigation